B/ s hyperkalcémií vyvolanou nádorovým onemocněním nereagujícím dostatečně na předchozí aplikaci jiných bisfosfonátů.
| 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | |
|---|
| 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,45 | H |
| 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | |
|---|
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H |
|
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 1852,76 | H |
| 55404 | AERRANE | inh sol 1x100ml | BXI | B |
| 55405 | AERRANE | inh sol 1x250ml | BXI | B |
| 10722 | ISOFLURAN RHODIA | inh sol 1x250ml | ROD | GB |
| 359.3 | N01AB07 | desfluran | inhal. | 100 | ML | 1407,00 | H |
|
| 359.4 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H |
| 360 | N01AF | injekční anestetika ze skupiny barbiturátů | parent. | |
|---|
| 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H |
|
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H |
|
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 38,85 | H |
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | |
|---|
| 361.1 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 137,80 | O |
| 30101 | FENTANYL TORREX 50MCG/ML | inj 5x2ml/100rg | TRX | A |
| 361.2 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 101,48 | O |
| 30102 | FENTANYL TORREX 50MCG/ML | inj 5x10ml/500rg | TRX | A |
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | |
|---|
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 46,89 | H |
| 87721 | RAPIFEN | inj sol 5x2ml/1mg | JAN | B |
| 362.2 | N01AH03 | sufentanyl (do 10 rg v ampuli včetně) | parent. | 0.6 | MG | 1344,54 | H |
| 93701 | SUFENTA | inj 5x2ml/10rg | JAN | B |
| 362.3 | N01AH03 | sufentanyl (nad 10 do 50 rg v ampuli včetně) | parent. | 0.6 | MG | 644,02 | H |
| 85526 | SUFENTA FORTE | inj 5x1ml/50rg | JAN | B |
| 30779 | SUFENTANIL TORREX 5 MCG/ML | inj sol 5x10ml/50rg | TRX | A |
| 21043 | SUFENTANIL TORREX 5 MCG/ML | inj sol10x10ml/50rg | TRX | A |
| 21044 | SUFENTANIL TORREX 5 MCG/ML | inj sol20x10ml/50rg | TRX | A |
| 362.4 | N01AH03 | sufentanyl (nad 50 rg v ampuli) | parent. | 0.6 | MG | 718,96 | H |
| 93702 | SUFENTA FORTE | inj 5x5ml/250rg | JAN | B |
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H |
|
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H |
| 363 | N01AX | ostatní celková anestetika | parent. | |
|---|
| 363.1 | N01AX03 | ketamin (koncetrace do 1% včetně) | parent. | 1 | GM | 240,19 | O |
|
| 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 1 | GM | 234,04 | O |
|
| 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,11 | O |
|
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O |
|
| 363.5 | N01AX10 | propofol – koncentrace do 1% včetně | parent. | 10 | ML | 87,00 | O |
| 53444 | PROPOFOL ABBOTT | inj eml 1x100ml | ABN | USA |
| 53441 | PROPOFOL ABBOTT | inj eml 5x20ml-am | ABN | USA |
| 53442 | PROPOFOL ABBOTT | inj eml 5x20ml-la | ABN | USA |
| 56671 | PROPOFOL GENTHON 10 MG/ML | injeml10x100ml/1gm | GNN | D |
| 56665 | PROPOFOL GENTHON 10 MG/ML | injeml10x20ml/200mg | GNN | D |
| 56668 | PROPOFOL GENTHON 10 MG/ML | injeml10x50ml/500mg | GNN | D |
| 56669 | PROPOFOL GENTHON 10 MG/ML | injeml1x100ml/1gm | GNN | D |
| 56663 | PROPOFOL GENTHON 10 MG/ML | injeml1x20ml/200mg | GNN | D |
| 56666 | PROPOFOL GENTHON 10 MG/ML | injeml1x50ml/500mg | GNN | D |
| 56670 | PROPOFOL GENTHON 10 MG/ML | injeml5x100ml/1gm | GNN | D |
| 56664 | PROPOFOL GENTHON 10 MG/ML | injeml5x20ml/200mg | GNN | D |
| 56667 | PROPOFOL GENTHON 10 MG/ML | injeml5x50ml/500mg | GNN | D |
| 44163 | RECOFOL | inj 1x50ml/500mg | LOY | SF |
| 75180 | RECOFOL | inj 5x20ml/200mg | LOY | SF |
| 363.6 | N01AX10 | propofol – 2% koncentrace | parent. | 10 | ML | 139,00 | O |
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | |
|---|
| 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O |
|
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
|
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,49 | O |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml | ARD | CZ |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml/500mg | ARD | CZ |
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml/1gm | ARD | CZ |
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml | ARD | CZ |
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml/1.25gm | ARD | CZ |
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml/2.5gm | ARD | CZ |
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml | ARD | CZ |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml | ARD | CZ |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml/5gm | ARD | CZ |
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | |
|---|
| 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,18 | O |
| 02684 | MESOCAIN | gel 1x20gm/200mg | SLO | SK |
Autokatetrizace močových cest prováděná pacientem v domácí péči.
| 365.2 | N01BB02 | lidokain (obsah 6 ml) | lok. | 1 | ML | 5,60 | P |
|
| 365.3 | N01BB02 | lidokain (obsah 11 ml) | lok. | 1 | ML | 3,90 | P |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | |
|---|
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ |
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ |
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,43 | O |
|
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ |
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
|
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O |
|
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| 06624 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 10x50ml | SLH | D |
| 06623 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 1x50ml | SLH | D |
| 06625 | BUPIVACAINE HYDROCHLORIDE 0.25% | inj sol 50x50ml | SLH | D |
| 06634 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 10x50ml | SLH | D |
| 06635 | BUPIVACAINE HYDROCHLORIDE 0.5% | inj sol 50x50ml | SLH | D |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 48,84 | O |
| 06640 | BUPIVACAINE HYDROCH0.5%HYPERBAR | inj sol 10x4ml | SLH | D |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj sol 5x4ml/20mg | AZC | D |
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
|
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O |
|
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O |
|
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 9,86 | O |
|
| 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O |
|
| 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O |
|
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O |
|
| 366.15 | N01BB10 | ropivacain | parent. | 1 | ML | 14,00 | O |
| 03755 | CHIROCAINE 2.5 MG/ML | inj sol 10x10ml | ABB | I |
| 03761 | CHIROCAINE 5 MG/ML | inj sol 10x10ml | ABB | I |
| 366.16 | N01BB09 | levobupivacain | parent. | 1 | ML | 14,00 | O |
| 46610 | NAROPIN 2 MG/ML | infsol5x100ml/200mg | AZC | S |
| 56038 | NAROPIN 2 MG/ML | inj sol5x10ml/20mg | AZC | S |
| 367 | N01BX | ostatní lokální anestetika | lok. | |
|---|
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. | |
|---|
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 | |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F |
| 94309 | MST CONTINUS 10MG | tbl ret 60x10mg | NPP | GB |
| 46256 | SKENAN L.P.10 MG | por cps rdr 14x10mg | EAD | F |
| 80405 | VENDAL RETARD 10MG | tbl obd 30x10mg | LAR | A |
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 | |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F |
| 94310 | MST CONTINUS 30MG | tbl ret 60x30mg | NPP | GB |
| 46258 | SKENAN L.P.30 MG | por cps rdr 14x30mg | EAD | F |
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK |
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK |
| 80406 | VENDAL RETARD 30MG | tbl obd 30x30mg | LAR | A |
| 368.3 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 | |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F |
| 94311 | MST CONTINUS 60MG | tbl ret 60x60mg | NPP | GB |
| 46260 | SKENAN L.P.60 MG | por cps rdr 14x60mg | EAD | F |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK |
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK |
| 80407 | VENDAL RETARD 60MG | tbl obd 30x60mg | LAR | A |
| 368.4 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 | |
| 46262 | SKENAN L.P.100 MG | por cps rdr14x100mg | EAD | F |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK |
| 80408 | VENDAL RETARD 100MG | tbl obd 30x100mg | LAR | A |
| 80409 | VENDAL RETARD 200MG | tbl obd 30x200mg | LAR | A |
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
|
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
|
| 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | |
|
| 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | |
|
| 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | |
|
| 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | |
|
| 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 54,20 | |
|
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 52,20 | |
|
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.15 | GM | 32,71 | |
| 56873 | DHC CONTINUS 60 MG | por tbl ret 20x60mg | NPP | GB |
| 80451 | DHC CONTINUS 60 MG | por tbl ret 56x60mg | NPP | GB |
| 56874 | DHC CONTINUS 90 MG | por tbl ret 20x90mg | NPP | GB |
| 80452 | DHC CONTINUS 90 MG | por tbl ret 56x90mg | NPP | GB |
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.15 | GM | 27,86 | |
| 56875 | DHC CONTINUS 120 MG | por tbl ret20x120mg | NPP | GB |
| 80453 | DHC CONTINUS 120 MG | por tbl ret56x120mg | NPP | GB |
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | |
|---|
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,45 | O |
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK |
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,33 | O |
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK |
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. | |
|---|
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | |
|
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 229,40 | P |
|
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 435,90 | P |
|
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 633,85 | P |
|
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 767,15 | P |